Cargando…
Integrated Analysis Identifies a Nine-microRNA Signature Biomarker for Diagnosis and Prognosis in Colorectal Cancer
BACKGROUND: Colorectal cancer (CRC) is the third most lethal and malignant type of cancer in the world. Abnormal expression of human microRNA-200a (hsa-miRNA-200a or miR-200a) has previously been characterized as a clinically noticeable biomarker in several cancers, but its role in CRC is still uncl...
Autores principales: | Di, Ziyang, Di, Maojun, Fu, Weihua, Tang, Qiang, Liu, Yanwei, Lei, Peijie, Gu, Xinsheng, Liu, Tong, Sun, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7100107/ https://www.ncbi.nlm.nih.gov/pubmed/32265979 http://dx.doi.org/10.3389/fgene.2020.00192 |
Ejemplares similares
-
Immune-Related Nine-MicroRNA Signature for Predicting the Prognosis of Gastric Cancer
por: Xu, Jingxuan, et al.
Publicado: (2021) -
Construction of a Nine-MicroRNA-Based Signature to Predict the Overall Survival of Esophageal Cancer Patients
por: Zhang, Xiaobin, et al.
Publicado: (2021) -
A Novel Nine-Gene Signature Associated With Immune Infiltration for Predicting Prognosis in Hepatocellular Carcinoma
por: Liu, Rongqiang, et al.
Publicado: (2021) -
Cancer diagnosis and prognosis decoded by blood-based circulating microRNA signatures
por: Madhavan, Dharanija, et al.
Publicado: (2013) -
Implications of microRNAs in Colorectal Cancer Development, Diagnosis, Prognosis, and Therapeutics
por: Zhai, Haiyan, et al.
Publicado: (2011)